To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalizatio
Phase 1
- Conditions
- ARMD,BRVO,CRVO,DR,CNV
- Registration Number
- JPRN-UMIN000000647
- Lead Sponsor
- Department of Ophtalmology of Keio University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Cr>3.0mg/dL anstable angina malignant arrhythmia HT:140/80mmHg>
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To acess side-effect and examin visual acuity,thickness of retina and retinal angiography
- Secondary Outcome Measures
Name Time Method